Purified CHO PLBL2 Protein
To Order Contact us: bjorn@lembcke.dk
Anti-CHO PLBL2 | GPLB-65B |
|||
| GPLB-65B | Immunology Consultants Laboratory | 0.5 mg | EUR 3169 |
|
Description: Anti-CHO PLBL2 | GPLB-65B | Immunology Consultants Laboratory Host: Goat Format: Biotin Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
|||
Anti-CHO PLBL2 | MPLB-65ALY-4D5 |
|||
| MPLB-65ALY-4D5 | Immunology Consultants Laboratory | 0.5 mg | EUR 3018 |
|
Description: Anti-CHO PLBL2 | MPLB-65ALY-4D5 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
|||
Anti-CHO PLBL2 | GPLB-65B-Z |
|||
| GPLB-65B-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 969 |
|
Description: Anti-CHO PLBL2 | GPLB-65B-Z | Immunology Consultants Laboratory Host: Goat Format: Biotin Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
|||
Anti-CHO PLBL2 | MPLB-65ALY-Z-4D5 |
|||
| MPLB-65ALY-Z-4D5 | Immunology Consultants Laboratory | 0.1 mg | EUR 969 |
|
Description: Anti-CHO PLBL2 | MPLB-65ALY-Z-4D5 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
|||
Recombinant Human HGF Protein, Untagged, CHO-10ug |
|||
| QP10665-CHO-10ug | EnQuireBio | 10ug | EUR 241.2 |
Recombinant Human HGF Protein, Untagged, CHO-1mg |
|||
| QP10665-CHO-1mg | EnQuireBio | 1mg | EUR 5343.6 |
Recombinant Human HGF Protein, Untagged, CHO-2ug |
|||
| QP10665-CHO-2ug | EnQuireBio | 2ug | EUR 186 |
Recombinant Mouse CD14 Protein, His, CHO-10ug |
|||
| QP11301-HIS-CHO-10ug | EnQuireBio | 10ug | EUR 708 |
Recombinant Mouse CD14 Protein, His, CHO-2ug |
|||
| QP11301-HIS-CHO-2ug | EnQuireBio | 2ug | EUR 294 |
Purified CHO GSTp Protein | AG65-0337 |
|||
| AG65-0337 | Immunology Consultants Laboratory | 1.0 mg | EUR 6110 |
|
Description: Purified CHO GSTp Protein | AG65-0337 | Immunology Consultants Laboratory Species Reactivity: CHO (S-cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
|||
Purified CHO GSTp Protein | AG65-0337-Z |
|||
| AG65-0337-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 818 |
|
Description: Purified CHO GSTp Protein | AG65-0337-Z | Immunology Consultants Laboratory Species Reactivity: CHO (S-cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
|||
Purified CHO Clusterin Protein | AG65-0075-01-Z |
|||
| AG65-0075-01-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 894 |
|
Description: Purified CHO Clusterin Protein | AG65-0075-01-Z | Immunology Consultants Laboratory Species Reactivity: CHO (S cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
|||
Purified CHO Legumain Protein | AG65-0423-01-Z |
|||
| AG65-0423-01-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 894 |
|
Description: Purified CHO Legumain Protein | AG65-0423-01-Z | Immunology Consultants Laboratory Species Reactivity: CHO (S cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
|||
Chinese Hamster Ovary Cell (CHO) host cell Proteins (HCPs) ELISA kit, 96 tests |
|||
| 800-140-CHO | Alpha Diagnostics | 1 kit | EUR 1000.8 |
Purified (CHO cells) Recombinant Human BMP7 protein, Biologically active |
|||
| BMP75-R-10 | Alpha Diagnostics | 10 ug | EUR 1074 |
Purified CHO MMP-19 Protein | AG65-0424-01-Z |
|||
| AG65-0424-01-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 894 |
|
Description: Purified CHO MMP-19 Protein | AG65-0424-01-Z | Immunology Consultants Laboratory Species Reactivity: CHO (S cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
|||
Purified CHO Nidogen-1 Protein | AG65-0426-01-Z |
|||
| AG65-0426-01-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 894 |
|
Description: Purified CHO Nidogen-1 Protein | AG65-0426-01-Z | Immunology Consultants Laboratory Species Reactivity: CHO (S cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
|||
CHO-PEG-CHO |
|||
| abx085042-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 510 |
CHO-PEG-CHO |
|||
| abx085042-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 477.6 |
CHO-PEG-CHO |
|||
| abx085042-34kDa1g | Abbexa | 3.4 kDa; 1 g | EUR 510 |
CHO-PEG-CHO |
|||
| abx085042-5kDa1g | Abbexa | 5 kDa; 1 g | EUR 510 |
Human (Cho cells) recombinant, purified BMP7 protein Western blot +ve control |
|||
| BMP71-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
CHO-PEG-CHO,10K |
|||
| 33-HO004004-10K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CHO-PEG-CHO,1K |
|||
| 33-HO004004-1K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CHO-PEG-CHO,20K |
|||
| 33-HO004004-20K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CHO-PEG-CHO,2K |
|||
| 33-HO004004-2K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CHO-PEG-CHO,3.4K |
|||
| 33-HO004004-3.4K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CHO-PEG-CHO,4K |
|||
| 33-HO004004-4K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CHO-PEG-CHO,5K |
|||
| 33-HO004004-5K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CD14 CHO Protein |
|||
| 20-abx260652 | Abbexa |
|
|
Hepatitis Surface Antigen subtype Adr (HBsAg Adr), Recombinant (CHO, >95%), purified |
|||
| HBA31-N-25 | Alpha Diagnostics | 25 ug | EUR 270 |
CHO antibody |
|||
| 70R-CG003 | Fitzgerald | 1 mg | EUR 3010.8 |
|
Description: Affinity purified Goat polyclonal CHO antibody |
|||
CHO antibody |
|||
| 20R-CG004 | Fitzgerald | 1 ml | EUR 678 |
|
Description: Goat polyclonal CHO antibody |
|||
mPEG-CHO |
|||
| abx085008-035kDa1g | Abbexa | 0.35 kDa; 1 g | EUR 577.2 |
mPEG-CHO |
|||
| abx085008-075kDa1g | Abbexa | 0.75 kDa; 1 g | EUR 610.8 |
mPEG-CHO |
|||
| abx085008-30kDa1g | Abbexa | 30 kDa; 1 g | EUR 610.8 |
Slit2, CHO |
|||
| PR15085 | Neuromics | 50 ug | EUR 553.2 |
HGF CHO |
|||
| PR27049 | Neuromics | 2 ug | EUR 229.2 |
Recombinant purified Mouse Klotho protein (CHO cells, His-tag; Alpha form; EC domain), active |
|||
| KL15-R | Alpha Diagnostics | 10 ug | EUR 343.2 |
Recombinant Hepatitis B HBsAg adr CHO Protein, Untagged, CHO-100ug |
|||
| QP12124-100ug | EnQuireBio | 100ug | EUR 241.2 |
Recombinant Hepatitis B HBsAg adr CHO Protein, Untagged, CHO-1mg |
|||
| QP12124-1mg | EnQuireBio | 1mg | EUR 1099.2 |
Recombinant Hepatitis B HBsAg adr CHO Protein, Untagged, CHO-20ug |
|||
| QP12124-20ug | EnQuireBio | 20ug | EUR 186 |
Hepatocyte Growth Factor, CHO Protein |
|||
| 20-abx263028 | Abbexa |
|
|
Ac-YVAD-CHO |
|||
| A8954-1 | ApexBio | 1 mg | EUR 134.4 |
|
Description: Ac-YVAD-CHO |
|||
Ac-YVAD-CHO |
|||
| A8954-10 | ApexBio | 10 mg | EUR 622.8 |
|
Description: Ac-YVAD-CHO |
|||
Ac-YVAD-CHO |
|||
| A8954-5 | ApexBio | 5 mg | EUR 360 |
|
Description: Ac-YVAD-CHO |
|||
CHO DNA Concentrate |
|||
| D552 | Cygnus Technologies | 1 ml | EUR 650.4 |
|
Description: CHO DNA Concentrate by Cygnus Technologies is available in Europe via Gentaur. |
|||
CHO DNA Concentrate |
|||
| D556 | Cygnus Technologies | 120 ul | EUR 562.8 |
|
Description: CHO DNA Concentrate by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO HCP |
|||
| C0016 | Cygnus Technologies | 1 ml | EUR 400.8 |
|
Description: Anti-CHO HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO HCP |
|||
| C0016-AF | Cygnus Technologies | 1 mg | EUR 2295.6 |
|
Description: Anti-CHO HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO HCP |
|||
| C0016-AFB | Cygnus Technologies | 1 mg | EUR 4143.6 |
|
Description: Anti-CHO HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO HCP |
|||
| C0016-PA | Cygnus Technologies | 1 ml | EUR 585.6 |
|
Description: Anti-CHO HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO HCP |
|||
| C0016AF-HRP | Cygnus Technologies | 1 mg | EUR 4882.8 |
|
Description: Anti-CHO HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
CHO HCP Standard |
|||
| F018G | Cygnus Technologies | 1 ml | EUR 308.4 |
|
Description: CHO HCP Standard by Cygnus Technologies is available in Europe via Gentaur. |
|||
CHO Control Antigen |
|||
| F063 | Cygnus Technologies | 50 ul | EUR 262.8 |
|
Description: CHO Control Antigen by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO HCP |
|||
| 3G-0016 | Cygnus Technologies | 1 ml | EUR 400.8 |
|
Description: Anti-CHO HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO HCP |
|||
| 3G-0016-AF | Cygnus Technologies | 1 mg | EUR 2295.6 |
|
Description: Anti-CHO HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO HCP |
|||
| 3G-0016-AFB | Cygnus Technologies | 1 mg | EUR 4143.6 |
|
Description: Anti-CHO HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO HCP |
|||
| 3G-0016-PA | Cygnus Technologies | 1 ml | EUR 585.6 |
|
Description: Anti-CHO HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
DSPE-PEG-CHO |
|||
| abx085154-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 1144.8 |
DSPE-PEG-CHO |
|||
| abx085154-1kDa1g | Abbexa | 1 kDa; 1 g | EUR 1144.8 |
DSPE-PEG-CHO |
|||
| abx085154-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 1144.8 |
FA-PEG-CHO |
|||
| abx085224-10kDa100mg | Abbexa | 10 kDa; 100 mg | EUR 744 |
FA-PEG-CHO |
|||
| abx085224-1kDa100mg | Abbexa | 1 kDa; 100 mg | EUR 727.2 |
FA-PEG-CHO |
|||
| abx085224-34kDa100mg | Abbexa | 3.4 kDa; 100 mg | EUR 744 |
FA-PEG-CHO |
|||
| abx085224-5kDa100mg | Abbexa | 5 kDa; 100 mg | EUR 744 |
AC-PEG-CHO |
|||
| abx085251-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 811.2 |
AC-PEG-CHO |
|||
| abx085251-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 811.2 |
AC-PEG-CHO |
|||
| abx085251-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 811.2 |
AC-PEG-CHO |
|||
| abx085251-5kDa1g | Abbexa | 5 kDa; 1 g | EUR 811.2 |
Alkyne-PEG-CHO |
|||
| abx085264-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 961.2 |
Alkyne-PEG-CHO |
|||
| abx085264-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 961.2 |
Alkyne-PEG-CHO |
|||
| abx085264-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 961.2 |
Alkyne-PEG-CHO |
|||
| abx085264-5kDa1g | Abbexa | 5 kDa; 1 g | EUR 961.2 |
CHO-PEG-COOH |
|||
| abx085268-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 878.4 |
CHO-PEG-COOH |
|||
| abx085268-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 878.4 |
CHO-PEG-COOH |
|||
| abx085268-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 878.4 |
CHO-PEG-COOH |
|||
| abx085268-5kDa1g | Abbexa | 5 kDa; 1 g | EUR 878.4 |
CHO-PEG-EPO |
|||
| abx085289-10kDa5g | Abbexa | 10 kDa; 5 g | EUR 2749.2 |
CHO-PEG-EPO |
|||
| abx085289-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 1045.2 |
CHO-PEG-EPO |
|||
| abx085289-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 1045.2 |
CHO-PEG-MA |
|||
| abx085290-10kDa5g | Abbexa | 10 kDa; 5 g | EUR 3032.4 |
CHO-PEG-MA |
|||
| abx085290-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 1144.8 |
CHO-PEG-MA |
|||
| abx085290-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 1144.8 |
CHO-PEG-Mal |
|||
| abx085291-10kDa5g | Abbexa | 10 kDa; 5 g | EUR 2749.2 |
CHO-PEG-Mal |
|||
| abx085291-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 1045.2 |
CHO-PEG-Mal |
|||
| abx085291-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 1045.2 |
CHO-PEG-SC |
|||
| abx085292-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 861.6 |
CHO-PEG-SC |
|||
| abx085292-10kDa5g | Abbexa | 10 kDa; 5 g | EUR 2180.4 |
CHO-PEG-SC |
|||
| abx085292-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 861.6 |
CHO-PEG-SC |
|||
| abx085292-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 861.6 |
CHO-PEG-N3 |
|||
| abx085293-10kDa5g | Abbexa | 10 kDa; 5 g | EUR 3032.4 |
CHO-PEG-N3 |
|||
| abx085293-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 1144.8 |
CHO-PEG-N3 |
|||
| abx085293-5kDa1g | Abbexa | 5 kDa; 1 g | EUR 1144.8 |
CHO-PEG-NH2 |
|||
| abx085294-10kDa5g | Abbexa | 10 kDa; 5 g | EUR 2581.2 |
CHO-PEG-NH2 |
|||
| abx085294-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 994.8 |
CHO-PEG-NH2 |
|||
| abx085294-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 994.8 |
CHO-PEG-OH |
|||
| abx085295-10kDa5g | Abbexa | 10 kDa; 5 g | EUR 2464.8 |
CHO-PEG-OH |
|||
| abx085295-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 961.2 |
CHO-PEG-OH |
|||
| abx085295-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 961.2 |
CHO-PEG-SH |
|||
| abx085296-10kDa5g | Abbexa | 10 kDa; 5 g | EUR 2749.2 |
CHO-PEG-SH |
|||
| abx085296-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 1045.2 |
CHO-PEG-SH |
|||
| abx085296-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 1045.2 |
Biotin-PEG-CHO |
|||
| abx085386-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 484.8 |
Biotin-PEG-CHO |
|||
| abx085386-34kDa1g | Abbexa | 3.4 kDa; 1 g | EUR 484.8 |
Ac-DEVD-CHO |
|||
| B1951-1 | Biovision | EUR 170.4 | |
Ac-DEVD-CHO |
|||
| B1951-5 | Biovision | EUR 496.8 | |
CHO-K1 cells |
|||
| P0017001 | Addexbio | One Frozen vial | EUR 546 |
mPEG-CHO,10K |
|||
| 33-MF001004-10K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-CHO,1K |
|||
| 33-MF001004-1K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-CHO,20K |
|||
| 33-MF001004-20K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-CHO,2K |
|||
| 33-MF001004-2K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-CHO,3.4K |
|||
| 33-MF001004-3.4K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-CHO,30K |
|||
| 33-MF001004-30K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-CHO,350 |
|||
| 33-MF001004-350 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-CHO,40K |
|||
| 33-MF001004-40K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-CHO,550 |
|||
| 33-MF001004-550 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-CHO,5K |
|||
| 33-MF001004-5K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-CHO,750 |
|||
| 33-MF001004-750 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Ac-DEVD-CHO |
|||
| HY-P1001 | MedChemExpress | 5mg | EUR 456 |
CHO-PEG-NH2,10K |
|||
| 33-HE004005-10K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CHO-PEG-NH2,20K |
|||
| 33-HE004005-20K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CHO-PEG-NH2,2K |
|||
| 33-HE004005-2K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CHO-PEG-NH2,5K |
|||
| 33-HE004005-5K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CHO-PEG-N3,10K |
|||
| 33-HE004006-10K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CHO-PEG-N3,20K |
|||
| 33-HE004006-20K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CHO-PEG-N3,2K |
|||
| 33-HE004006-2K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CHO-PEG-N3,5K |
|||
| 33-HE004006-5K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
BMP-7 CHO |
|||
| PR27001 | Neuromics | 2 ug | EUR 229.2 |
CHO-hNCX1 cells |
|||
| S0017001 | Addexbio | One Frozen vial | EUR 1213.2 |
CHO-hTRPV1 cells |
|||
| S0017002 | Addexbio | One Frozen vial | EUR 1213.2 |
Bone Morphogenetic protein-7, CHO Protein |
|||
| 20-abx263081 | Abbexa |
|
|
Angiopoietin-2, Human Recombinant Protein, CHO |
|||
| CG1003-010 | GenDepot | 10 ug | EUR 408 |
Angiopoietin-2, Human Recombinant Protein, CHO |
|||
| CG1003-025 | GenDepot | 25 ug | EUR 643.2 |
beta Nerve Growth Factor, CHO Protein |
|||
| 20-abx260714 | Abbexa |
|
|
Vascular Endothelial Growth Factor, CHO Protein |
|||
| 20-abx262337 | Abbexa |
|
|
Granulocyte-Colony Stimulating Factor, CHO Protein |
|||
| 20-abx262391 | Abbexa |
|
|
Human, CD14 Human Recombinant Protein, CHO |
|||
| PROTP08571 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: The CD14 is produced from human CD14 transfected CHO-cells. Before transfection the complete human CD14-cDNA was amplified by PCR and cloned into expression vector p-POL-DHFR. The myeloid differentiation antigen CD14 acts as the major receptor for bacterial LPS. The dominant form of the recombinant wild type CD14 is the 50-kDa protein containing 335 amino acids and lacks the GPI-Anchor. |
|||
Recombinant purified Mouse Klotho protein (CHO cells, His-tag; Alpha form; EC domain) control for western blot |
|||
| KL12-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
8-ArmPEG-CHO,10K |
|||
| 33-A88004-10K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-CHO,20K |
|||
| 33-A88004-20K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-CHO,2K |
|||
| 33-A88004-2K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
8-ArmPEG-CHO,5K |
|||
| 33-A88004-5K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
rHu BMP-4 (CHO) |
|||
| AK9996-0005 | Akron Biotech | 5µg | Ask for price |
rHu BMP-4 (CHO) |
|||
| AK9996-0020 | Akron Biotech | 20µg | Ask for price |
rHu BMP-4 (CHO) |
|||
| AK9996-0100 | Akron Biotech | 100µg | Ask for price |
rHu BMP-4 (CHO) |
|||
| AK9996-1000 | Akron Biotech | 1mg | Ask for price |
CHO HCP ELISA kit |
|||
| F015 | Cygnus Technologies | 1 kit (96 wells plate) | EUR 1296 |
|
Description: CHO HCP ELISA kit by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO Biotinylated Concentrate |
|||
| F017B | Cygnus Technologies | 1 mg | EUR 3774 |
|
Description: Anti-CHO Biotinylated Concentrate by Cygnus Technologies is available in Europe via Gentaur. |
|||
CHO HCP Standard D |
|||
| F018D | Cygnus Technologies | 1.5 ml | EUR 262.8 |
|
Description: CHO HCP Standard D by Cygnus Technologies is available in Europe via Gentaur. |
|||
CHO HCP Standard F |
|||
| F018F | Cygnus Technologies | 1.5 ml | EUR 262.8 |
|
Description: CHO HCP Standard F by Cygnus Technologies is available in Europe via Gentaur. |
|||
CHO Lysate Antigen Concentrate |
|||
| F018H | Cygnus Technologies | 200 ul | EUR 724.8 |
|
Description: CHO Lysate Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur. |
|||
CHO Lysate Antigen Concentrate |
|||
| F018R | Cygnus Technologies | 1 ml | EUR 7470 |
|
Description: CHO Lysate Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur. |
|||
CHO HCP WB kit |
|||
| F060 | Cygnus Technologies | 1 kit (application dependant amount of reactions) | EUR 1003.2 |
|
Description: CHO HCP WB kit by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO-CM:HRP Conjugate |
|||
| F119 | Cygnus Technologies | 50 ml | EUR 355.2 |
|
Description: Anti-CHO-CM:HRP Conjugate by Cygnus Technologies is available in Europe via Gentaur. |
|||
CHO-CM Standard G |
|||
| F139G | Cygnus Technologies | 1 ml | EUR 234 |
|
Description: CHO-CM Standard G by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO-CM:HRP Conjugate |
|||
| F148 | Cygnus Technologies | 12 ml | EUR 632.4 |
|
Description: Anti-CHO-CM:HRP Conjugate by Cygnus Technologies is available in Europe via Gentaur. |
|||
CHO HCP Standard F |
|||
| F553F | Cygnus Technologies | 1 ml | EUR 234 |
|
Description: CHO HCP Standard F by Cygnus Technologies is available in Europe via Gentaur. |
|||
CHO HCP Antigen Concentrate |
|||
| F553V | Cygnus Technologies | 1 ml | EUR 9318 |
|
Description: CHO HCP Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur. |
|||
Recombinant Human Thrombopoietin, CHO |
|||
| 7-01690 | CHI Scientific | 2µg | Ask for price |
Recombinant Human Thrombopoietin, CHO |
|||
| 7-01691 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Thrombopoietin, CHO |
|||
| 7-01692 | CHI Scientific | 1mg | Ask for price |
8-Arm PEG-CHO |
|||
| abx085104-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 393.6 |
8-Arm PEG-CHO |
|||
| abx085104-10kDa5g | Abbexa | 10 kDa; 5 g | EUR 744 |
8-Arm PEG-CHO |
|||
| abx085104-20kDa5g | Abbexa | 20 kDa; 5 g | EUR 744 |
8-Arm PEG-CHO |
|||
| abx085104-40kDa1g | Abbexa | 40 kDa; 1 g | EUR 427.2 |
4-Arm PEG-CHO |
|||
| abx085169-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 427.2 |
4-Arm PEG-CHO |
|||
| abx085169-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 427.2 |
4-Arm PEG-CHO |
|||
| abx085169-2kDa5g | Abbexa | 2 kDa; 5 g | EUR 878.4 |
4-Arm PEG-CHO |
|||
| abx085169-5kDa1g | Abbexa | 5 kDa; 1 g | EUR 427.2 |
4-ArmPEG-CHO,10K |
|||
| 33-A44004-10K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
4-ArmPEG-CHO,20K |
|||
| 33-A44004-20K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
4-ArmPEG-CHO,2K |
|||
| 33-A44004-2K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
4-ArmPEG-CHO,5K |
|||
| 33-A44004-5K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Anti-CHO-CM HCP |
|||
| M0016 | Cygnus Technologies | 1 ml | EUR 400.8 |
|
Description: Anti-CHO-CM HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO-CM HCP |
|||
| M0016-AF | Cygnus Technologies | 1 mg | EUR 2295.6 |
|
Description: Anti-CHO-CM HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO-CM HCP |
|||
| M0016-AFB | Cygnus Technologies | 1 mg | EUR 4143.6 |
|
Description: Anti-CHO-CM HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO-CM HCP |
|||
| M0016-PA | Cygnus Technologies | 1 ml | EUR 585.6 |
|
Description: Anti-CHO-CM HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO-CM HCP |
|||
| M0016AF-AP | Cygnus Technologies | 1 mg | EUR 4513.2 |
|
Description: Anti-CHO-CM HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-CHO-CM HCP |
|||
| M0016AF-HRP | Cygnus Technologies | 1 mg | EUR 4882.8 |
|
Description: Anti-CHO-CM HCP by Cygnus Technologies is available in Europe via Gentaur. |
|||
Epigen (CHO-expressed), Human |
|||
| HY-P7010A | MedChemExpress | 10ug | EUR 157.2 |
Noggin (CHO-expressed), Human |
|||
| HY-P7051A | MedChemExpress | 10ug | EUR 224.4 |
Noggin (CHO-expressed), Mouse |
|||
| HY-P7086 | MedChemExpress | 10ug | EUR 224.4 |
TPO (CHO-expressed), Mouse |
|||
| HY-P7088 | MedChemExpress | 50ug | EUR 872.4 |
EGF (CHO-expressed), Rat |
|||
| HY-P7092A | MedChemExpress | 10ug | EUR 170.4 |
HGF (CHO-expressed), Human |
|||
| HY-P7121 | MedChemExpress | 10ug | EUR 267.6 |
Adiponectin (CHO-expressed), Human |
|||
| HY-P7126 | MedChemExpress | 10ug | EUR 253.2 |
CXCL3 (CHO-expressed), Rat |
|||
| HY-P7152 | MedChemExpress | 50ug | EUR 680.4 |
EPO (CHO-expressed), Human |
|||
| HY-P7164 | MedChemExpress | 10ug | EUR 170.4 |
Neuroserpin (CHO-expressed), Human |
|||
| HY-P7270 | MedChemExpress | 50ug | EUR 432 |